Previous literature has demonstrated that supplemental magnesium may have a prophylactic effect on noise induced hearing loss (NIHL). The purpose of this study was to replicate the findings of a previous investigation concerning the beneficial effects of supplemental magnesium on TTS in humans. Forty participants with normal hearing were divided into two groups, experimental and control. The experimental group received a single, 150 mg dose of supplemental magnesium and the control group received a placebo. After an hour in a quiet environment, all participants were exposed to a narrowband noise centered at 2000 Hz and presented at 105 dB SPL. Audiometric thresholds were measured for the frequency range 250 Hz - 8000 Hz prior to the noise exposure, and then immediately, 30 minutes, and 60 minutes post-noise exposure. Both groups experienced TTS at and above 2000 Hz. The largest TTS was observed immediately following the noise exposure in both groups. There was no significant difference in TTS between the experimental group and the control group. It was concluded that a single dose of 150 mg of supplemental magnesium was not effective in reducing or preventing TTS.

Previous studies have shown that supplemental magnesium administered prior to exposure to noise has an alleviating effect on temporary threshold shift (TTS). These studies have only used audiometric thresholds to demonstrate changes in the auditory system. However, to help determine the effects on outer hair cells (OHCs), a more sensitive measure should be used. The purpose of this study was to determine if supplemental magnesium administration prior to noise exposure has a beneficial effect on acoustic overexposure using a double-blind research design. This was determined by measuring distortion product otoacoustic emissions (DPOAEs) to determine any changes in cochlear OHC function. DPOAE amplitude and signal-to-noise ratio (SNR) measurements were analyzed for two groups of twenty participants (an experimental group and a control group). The experimental group received 150 mg of magnesium gluconate one hour prior to noise exposure. The control group received a placebo pill that was identical in appearance to the magnesium pill. Following noise exposure, the greatest changes in DPOAE amplitude and SNR occurred for the frequencies that were one-half to one octave above the frequency of the stimuli used. The greatest changes in DPOAE measurements were present immediately post TTS-inducing stimulus, with only slight changes present after 30 minutes and no difference between 30 minutes and 60 minutes post-exposure. These results were the same for both groups. It was concluded that this dosage of supplemental magnesium had no apparent protective effect on DPOAEs following intense noise exposure.